British Journal of Haematology, 0007-1048

Journal

View graph of relations

Related Publications
  1. Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study

    de Bruijn, C. M. A., Millot, F., Suttorp, M., Borisevich, M., Brons, P., Lausen, B. & de Bont, E. S. J. M., May-2019, In : British Journal of Haematology. 185, 4, p. 718-724 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP

    Adams, H. J. A. & Kwee, T. C., May-2019, In : British Journal of Haematology. 185, 4, p. 758-760 3 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  3. Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

    Rauert-Wunderlich, H., Mottok, A., Scott, D. W., Rimsza, L. M., Ott, G., Klapper, W., Unterhalt, M., Kluin-Nelemans, H. C., Hermine, O., Hartmann, S., Thorns, C., Rymkiewicz, G., Holte, H., Dreyling, M., Hoster, E. & Rosenwald, A., Feb-2019, In : British Journal of Haematology. 184, 4, p. 616-624 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation

    Ofran, Y., Beohou, E., Labopin, M., Blaise, D., Cornelissen, J. J., de Groot, M. R., Socie, G., Huynh, A., Maertens, J., Baron, F., Mohty, M. & Nagler, A., Feb-2019, In : British Journal of Haematology. 184, 4, p. 643-646 4 p.

    Research output: Contribution to journalLetterAcademicpeer-review

View all (184) »

ID: 1541074